Fidelity Investments’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$29.8M Buy
538,432
+60,089
+13% +$3.32M ﹤0.01% 1568
2025
Q1
$23.1M Buy
478,343
+35,827
+8% +$1.73M ﹤0.01% 1630
2024
Q4
$17.1M Sell
442,516
-11,680
-3% -$451K ﹤0.01% 1780
2024
Q3
$20.4M Buy
454,196
+19,737
+5% +$888K ﹤0.01% 1698
2024
Q2
$15.1M Sell
434,459
-31,626
-7% -$1.1M ﹤0.01% 1746
2024
Q1
$13.5M Buy
466,085
+133
+0% +$3.85K ﹤0.01% 1784
2023
Q4
$10.7M Sell
465,952
-43,290
-9% -$993K ﹤0.01% 1832
2023
Q3
$8.49M Buy
509,242
+1,835
+0.4% +$30.6K ﹤0.01% 1868
2023
Q2
$14M Buy
507,407
+459,087
+950% +$12.7M ﹤0.01% 1763
2023
Q1
$1.11M Sell
48,320
-20,206
-29% -$465K ﹤0.01% 2503
2022
Q4
$748K Sell
68,526
-2,740,282
-98% -$29.9M ﹤0.01% 2612
2022
Q3
$23.7M Sell
2,808,808
-682,198
-20% -$5.75M ﹤0.01% 1559
2022
Q2
$27.6M Sell
3,491,006
-3,637,573
-51% -$28.8M ﹤0.01% 1525
2022
Q1
$169M Buy
7,128,579
+281,302
+4% +$6.66M 0.01% 854
2021
Q4
$234M Buy
6,847,277
+354,639
+5% +$12.1M 0.02% 743
2021
Q3
$115M Sell
6,492,638
-623,745
-9% -$11.1M 0.01% 1040
2021
Q2
$319M Buy
7,116,383
+545,156
+8% +$24.5M 0.03% 629
2021
Q1
$170M Buy
6,571,227
+118,463
+2% +$3.07M 0.01% 860
2020
Q4
$130M Buy
6,452,764
+1,251,683
+24% +$25.2M 0.01% 927
2020
Q3
$102M Buy
5,201,081
+35,876
+0.7% +$701K 0.01% 895
2020
Q2
$91.2M Buy
5,165,205
+1,071,061
+26% +$18.9M 0.01% 907
2020
Q1
$28.9M Buy
4,094,144
+13,177
+0.3% +$93K ﹤0.01% 1255
2019
Q4
$28.8M Buy
4,080,967
+138,955
+4% +$980K ﹤0.01% 1456
2019
Q3
$47.3M Buy
3,942,012
+432,608
+12% +$5.2M 0.01% 1184
2019
Q2
$42.5M Sell
3,509,404
-97,845
-3% -$1.18M 0.01% 1307
2019
Q1
$45.3M Sell
3,607,249
-20,653
-0.6% -$260K 0.01% 1258
2018
Q4
$24.4M Buy
3,627,902
+170,500
+5% +$1.15M ﹤0.01% 1483
2018
Q3
$35.6M Buy
3,457,402
+276,819
+9% +$2.85M ﹤0.01% 1436
2018
Q2
$21.4M Buy
3,180,583
+15,017
+0.5% +$101K ﹤0.01% 1695
2018
Q1
$27.2M Buy
3,165,566
+93,617
+3% +$804K ﹤0.01% 1581
2017
Q4
$63.9M Buy
3,071,949
+536,535
+21% +$11.2M 0.01% 1183
2017
Q3
$44.8M Buy
2,535,414
+6,952
+0.3% +$123K 0.01% 1353
2017
Q2
$28.6M Buy
2,528,462
+10,264
+0.4% +$116K ﹤0.01% 1529
2017
Q1
$32.3M Buy
2,518,198
+11,031
+0.4% +$141K ﹤0.01% 1500
2016
Q4
$55.1M Buy
2,507,167
+378,448
+18% +$8.32M 0.01% 1255
2016
Q3
$45M Buy
+2,128,719
New +$45M 0.01% 1345